Metaplastic Breast Cancer Global Alliance

Supporting the advancement of research into Metaplastic Carcinoma of the Breast #metaplasticbreastcancer #Metaplastic #MpBC

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

If you want to learn more subscribe to our new Utube channel https://t.co/Ho4C0Syd8f

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@truthplease4me @DrPatrick Metaplastic would like to know also!

[Wafik S. El-Deiry, MD, PhD, FACP @weldeiry]

Let’s just focus on the effect of Covid mRNA vaccines on tumor PD-L1 expression. Not on adding immunotherapy. The question here is only about Covid mRNA vaccination and the impact of increased PD-L1 expression in an existing tumor in the vaccinated individual. You do not need to sugarcoat this or qualify your response in any way by adding a potential intervention to the created problematic effect. Be honest @grok

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

Scary times…

[Wafik S. El-Deiry, MD, PhD, FACP @weldeiry]

Science will never be the same after it got to this point👇and the people making money out of this are not actually contributing to science. More like destruction of science in my opinion.

Harvard-affiliated Dana-Farber to pay $15 million to settle US claims over flawed studies
https://t.co/7sesfblKzY

https://t.co/GfpAkyIrEz

Sholto David who is part of the inner circle of PubPeer gets $2.63 million out of this.

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@SabinehazanMD @weldeiry Community of patients here… 😐

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@weldeiry …concerning…. ???

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@drpatrick Contact us PLEASE!!!

[Nour Abuhadra @NAbuhadra]

🚨Thrilled to share our latest: the largest prospective study on predictors of response to neoadjuvant KN-522 in metaplastic TNBC. Long overdue for MpBC patients to have biology-driven data! #bcsm #metaplastic #TNBC @MpBCGA

https://t.co/YREaLRWqFV

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@PTarantinoMD @dr_yakupergun Treating oncologists are not all in agreement on what’s best for our community. We the patients feel like we are Guinea Pigs at this time!

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@dr_yakupergun Our community is experiencing devastating consequences due to the switch to neoadjuvant as a primary treatment. Our youngest member are showing the devastating consequences. Surgery was first in the 2000’s and I’m alive today at stg 4. This needs to change!

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@Dr_RShatsky Thank you!

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@Dr_RShatsky our community would like your input please!

[Peter A. McCullough, MD, MPH® @P_McCulloughMD]

NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients

Breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy.

The NIH National Cancer Institute should begin large scale multi-center, double-blind randomized trials across a broad array of cancers. @theNCI @McCulloughFund https://t.co/H9UJt6I5Tn

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@Dr_RShatsky here is the studies for your professional input please!

[Nicolas Hulscher, MPH @NicHulscher]

🚨BREAKING: Fenbendazole Linked to Remission or Near-Remission in THREE Stage IV Cancer Patients

New study reports breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy 👇

✅Case 1: 83-year-old woman, Stage IV Breast → Complete Remission (3 years)

✅Case 2: 75-year-old man, Stage IV Prostate → Near-Complete Remission (26 months, undetectable PSA)

✅Case 3: 63-year-old man, Stage IV Melanoma → Complete Remission (11 months)

Outcomes mirror preclinical findings on fenbendazole’s anti-cancer activity. Similar to ivermectin, fenbendazole may act as a powerful anticancer agent.

Clinical trials should be urgently initiated to test fenbendazole’s true potential.

Shoutout to @MakisMD for conducting this critically important study.

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@weldeiry Okay, we’re a global organization. US fares much better than other countries so let’s see Canada and the UK do better!?! We try sooooo hard to help our DX sisters and they die trying to get here in the US for treatments!

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@weldeiry @MdBatra I see it now, Thank you

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@MdBatra @weldeiry Some of us can pay to read the article

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@weldeiry Have to pay to read the article

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

@KristerKauppi I was on Everolimus for stg 4. Isn’t Rapamycin related to Everolimus?

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

Can this support cancer treatments for those tested to have the PI3K/mTOR?

[Krister Kauppi - Rapamycin Longevity Lab @KristerKauppi]

This is a sneak peek at a paper I'm currently writing on Omipalisib, also known as GSK2126458. Last year my lab discovered in roundworms that this dual PI3K/mTOR inhibitor has impressive lifespan-extending effects. In the paper I will share the current findings around the compound and the future steps ahead.

One part I’m currently working on is a simplified overview of the main pathways connected to Omipalisib. In this post I’m sharing the first draft of that image which I plan to include in the paper. I would love to get your feedback on it. All feedback is welcome, even the really tough one.

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

Program Guide – ASCO Meeting Program Guide #metaplastic https://t.co/JvW4hIH3JC

[Metaplastic Breast Cancer Global Alliance @MpBCGA]

Program Guide – ASCO Meeting Program Guide #metaplastic https://t.co/ALpvAoiOCI